We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$333B
AUM Growth
-$5.65B
Cap. Flow
+$10.7B
Cap. Flow %
3.22%
Top 10 Hldgs %
17.75%
Holding
3,695
New
106
Increased
2,783
Reduced
461
Closed
115

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$727M
2
HD icon
Home Depot
HD
+$472M
3
PFE icon
Pfizer
PFE
+$362M
4
TXN icon
Texas Instruments
TXN
+$314M
5
LYB icon
LyondellBasell Industries
LYB
+$299M

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Financials 12.97%
3 Healthcare 12.01%
4 Consumer Discretionary 10.22%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEPA
3551
DELISTED
Hepion Pharmaceuticals
HEPA
$41K ﹤0.01%
32
SEGG
3552
Sports Entertainment Gaming Global Corp
SEGG
$1.6M
$41K ﹤0.01%
65
OTIC
3553
DELISTED
Otonomy, Inc.
OTIC
$41K ﹤0.01%
16,843
ENZ
3554
DELISTED
Enzo Biochem, Inc.
ENZ
$40K ﹤0.01%
13,471
WMC
3555
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$40K ﹤0.01%
2,307
BCLI
3556
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$38K ﹤0.01%
752
RCAT icon
3557
Red Cat Holdings
RCAT
$1.15B
$38K ﹤0.01%
+18,398
New +$35.4K
SPRB
3558
Spruce Biosciences
SPRB
$118M
$38K ﹤0.01%
246
FBRX icon
3559
Forte Biosciences
FBRX
$1.57B
$37K ﹤0.01%
992
LUCD icon
3560
Lucid Diagnostics
LUCD
$166M
$37K ﹤0.01%
10,913
BTCY
3561
DELISTED
Biotricity, Inc. Common Stock
BTCY
$37K ﹤0.01%
2,667
WTER
3562
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$37K ﹤0.01%
2,653
AQMS icon
3563
Aqua Metals
AQMS
$8.99M
$36K ﹤0.01%
118
MBRX icon
3564
Moleculin Biotech
MBRX
$2.83M
$36K ﹤0.01%
54
SREV
3565
DELISTED
ServiceSource International, Inc.
SREV
$35K ﹤0.01%
26,733
UPH
3566
DELISTED
UpHealth, Inc.
UPH
$34K ﹤0.01%
2,800
DMK
3567
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$33K ﹤0.01%
804
TUEM
3568
DELISTED
Tuesday Morning Corp
TUEM
$33K ﹤0.01%
971
NRXP icon
3569
NRX Pharmaceuticals
NRXP
$135M
$30K ﹤0.01%
1,200
GALT icon
3570
Galectin Therapeutics
GALT
$196M
$29K ﹤0.01%
17,413
ROI
3571
DELISTED
RiskOn International, Inc. Common Stock
ROI
$25K ﹤0.01%
356
MDVL
3572
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$25K ﹤0.01%
497
EMAN
3573
DELISTED
eMagin Corporation
EMAN
$25K ﹤0.01%
21,824
TIO
3574
DELISTED
Tingo Group, Inc. Common Stock
TIO
$25K ﹤0.01%
40,861
EVFM
3575
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$23K ﹤0.01%
4,509

Similar funds

Charles Schwab's Q1 2022 Portfolio in Review

As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.

  • Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
  • Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
  • Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
  • Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
  • Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
  • Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.